ME Therapeutics Holdings Inc. (CSE:METX)
2.150
+0.650 (43.33%)
At close: Aug 28, 2026
-43.42% (1Y)
| Market Cap | 65.34M -41.9% |
| Revenue (ttm) | n/a |
| Net Income | -1.38M |
| EPS | -0.05 |
| Shares Out | 30.39M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 475 |
| Open | 2.000 |
| Previous Close | 1.500 |
| Day's Range | 2.000 - 2.150 |
| 52-Week Range | 0.790 - 8.000 |
| Beta | 0.01 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 27, 2026 |